Skip to content
healthcare.dev

LEQVIO

NDC 0078-1000, inclisiran, injection, solution, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-1000
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1000 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INCLISIRAN SODIUM284 mg/1.5mL
Package NDCNDC-11Package
0078-1000-60000781000601 SYRINGE, GLASS in 1 CARTON (0078-1000-60) / 1.5 mL in 1 SYRINGE, GLASS
0078-1000-98000781000981 SYRINGE, GLASS in 1 CARTON (0078-1000-98) / 1.5 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6fc0afca-4513-4c35-b594-6544aee29a44
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0078-1000

Use it

Look up 0078-1000 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1000 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-1000. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.